Scroll for more

blog

Nov 2, 2017 jackie hunter

The AI Industry Must Embrace Diversity Or Risk Reinforcing The Status Quo

Professor Jackie Hunter, CEO of BenevolentBio, writes for The Huffington Post on diversity in the AI industry and how it has the chance to embrace it or risk going the same way as many other industries.

Oct 5, 2017 jackie hunter

Why it’s essential the AI sector reflects society at large

Jackie Hunter explains why we need to encourage diversity in AI in a co-ordinated effort across the home, at school, at university and into the workplace.

Apr 10, 2017 jackie hunter

Thoughts on Science Policy

On the surface science policy may appear to be rather a dry subject, but it is fundamental to academic research and its positive knock-on effect for innovation in industry. 

Feb 20, 2017 jackie hunter

Wither pharmaceutical innovation?

Let’s talk pharmaceutical innovation, and in doing so let’s be honest and perhaps a little controversial. Last year the CEO of Regeneron, Leonard Schleifer, stood up at the Forbes Healthcare Summit in New York and said something surprisingly candid and revealing.

Dec 21, 2016 jackie hunter

I'm buying science presents for Christmas this year

It’s the last week before Christmas and a good time for reflection, to pause for breath and to think about what the next year will bring.

Nov 5, 2016 jackie hunter

In five years' time… Key trends in AI healthcare

10 years ago I attended a symposium looking at the future of pharmacology and healthcare.

Oct 7, 2016 jackie hunter

What happens when you put expert human brains in a room to discuss machine brains?

These are truly exciting times for artificial intelligence (“AI”) and bioscience. This month, together with The Crick and Turing Institutes and the Wellcome Trust, we co-hosted the first of what we anticipate will be an annual symposium on ‘Artificial Intelligence in Bioscience’.